| __timestamp | MannKind Corporation | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 1860000 |
| Thursday, January 1, 2015 | 108402000 | 2963000 |
| Friday, January 1, 2016 | 46928000 | 6961000 |
| Sunday, January 1, 2017 | 74959000 | 11779000 |
| Monday, January 1, 2018 | 79716000 | 13697000 |
| Tuesday, January 1, 2019 | 74669000 | 15749000 |
| Wednesday, January 1, 2020 | 59040000 | 18638000 |
| Friday, January 1, 2021 | 77417000 | 27196000 |
| Saturday, January 1, 2022 | 91473000 | 31739000 |
| Sunday, January 1, 2023 | 94314000 | 33491000 |
Cracking the code
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Protagonist Therapeutics, Inc. and MannKind Corporation from 2014 to 2023. Over this period, MannKind consistently reported higher SG&A expenses, peaking in 2015 with a 38% increase from the previous year. In contrast, Protagonist Therapeutics showed a steady upward trend, with expenses growing nearly 18-fold from 2014 to 2023. This growth reflects the company's expansion and increased investment in administrative capabilities. Notably, in 2023, Protagonist's SG&A expenses reached 45% of MannKind's, highlighting its rapid growth trajectory. These insights underscore the strategic financial management required in the biotech sector, where balancing operational costs with innovation is key to long-term success.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or MannKind Corporation
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared